Galapagos

Galapagos is a leading biotechnology company that specializes in discovering and developing innovative medicines to improve the lives of patients suffering from serious diseases. Our research and development team is dedicated to advancing the understanding of disease biology and developing transformative therapies for a range of diseases, including inflammation, fibrosis, and oncology. We operate with integrity, transparency, and a patient-centric approach, striving to be a leader in the biotech industry. With headquarters in Belgium and operations in the United States and Europe, we are a global company passionate about innovation and committed to improving healthcare outcomes.